NASDAQ: EDSA
Edesa Biotech Inc Stock Ownership - Who owns Edesa Biotech?

Insider buying vs selling

Have Edesa Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick MarshallDirector2025-02-1241,666$1.92
$80.00kBuy
Carlo SistilliDirector2025-02-1210,416$1.92
$20.00kBuy

1 of 1

EDSA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDSA insiders and whales buy or sell their stock.

EDSA Shareholders

What type of owners hold Edesa Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pardeep Nijhawan71.36%5,947,424$9.04MInsider
Der Velden Peter Van23.41%1,950,862$2.97MInsider
Stonepine Capital Management LLC8.25%687,500$1.05MInstitution
Velan Capital Investment Management LP8.25%687,500$1.05MInstitution
Rubric Capital Management LP8.25%687,500$1.05MInstitution
Nantahala Capital Management LLC7.50%625,000$950.00kInstitution
Herbert S. Chow6.74%561,767$853.89kInsider
Michael J. Brooks2.70%224,870$341.80kInsider
Mary Catherine Brisson1.86%154,680$235.11kInsider
Peter J. Weiler0.78%65,000$98.80kInsider

1 of 3

EDSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDSA23.97%76.03%Net Buying
CMMB0.08%3.44%
SNGX1.31%98.69%Net BuyingNet Buying
AEON4.75%95.25%Net Buying
LGVN4.90%78.53%Net SellingNet Selling

Edesa Biotech Stock Ownership FAQ

Who owns Edesa Biotech?

Edesa Biotech (NASDAQ: EDSA) is owned by 34.52% institutional shareholders, 109.48% Edesa Biotech insiders, and 0.00% retail investors. Pardeep Nijhawan is the largest individual Edesa Biotech shareholder, owning 5.95M shares representing 71.36% of the company. Pardeep Nijhawan's Edesa Biotech shares are currently valued at $8.74M.

If you're new to stock investing, here's how to buy Edesa Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.